医思医疗(02138.HK)折让10.3%发行股份及现金共3.38亿元购医学实验室测试服务
医思医疗(02138.HK)公布,间接全资附属Jade Master International Limited以总代价3.38亿元,向Sunny Sea Global Limited收购本港为医生及医疗机构提供医学实验室测试之服务的75%股权。
代价中2.3亿元将以现金支付,其余则以发行价值1.08亿元的代价股份支付,即1,990.78万股,占公司扩大後股本1.88%。发行价5.425元,较股份上一个交易日收市价6.05元折让10.3%。
另外,公司将於相关交易完成时或之前,与交易各方订立保留文件,於相关交易後,保留股份将转让予主要人员,主要人员将不可撤回地向买方授出买入选择权。受买卖协议的条款及条件所限,买方将按最後一批代价购买而卖方将出售最後一批销售股份,相关代价最高为2.38亿元。完成後,买方将持有目标公司全部已发行股本的97%,其余3%将由主要人员持有。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.